HS-20094
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Regeneron · Phase 2 · Recruiting · Enrollment 360
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Olatorepatide arm 1 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Olatorepatide arm 2 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Olatorepatide arm 3 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Olatorepatide arm 4 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Olatorepatide arm 5 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Matching Placebo arm 6 | Obesity or overweight | n/r | n/r | n/r | n/r |